Science and engineering

NEC Corporation (NEC; TSE: 6701) and Nidec Corporation announced today the successful joint development of a technology that enables highly precise, real-time remote control of Intelligent Motors, motors incorporating microcomputers through a wireless network.

Walgreens Boots Alliance to Invest in Chinese Pharmacy Chain GuoDa

Scientists at the CRUK Manchester Institute, based at The University of Manchester, have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning.

3-Worx has launched a subscription-based model for gaming and is adding new games to its platform with the help of Mobovivo.

This partnership will provide enhanced end-to-end inspection services to customers at a global scale.

KAMAZ's experts took part in the international conference Energy Saving. Science and Education held in Naberezhnye Chelny.

With the favorable decision of the Paris Commercial court approving the safeguard plan further to the approval of the resolutions necessary to implement the plan by the extraordinary general meeting and the confirmation judgement for the Chapter 11 in the United States.

Researchers aimed to answer an age-old question: Why do we like what we like?

Researchers have identified a potential cause of the mysterious patches on Earth's core that dampen seismic waves.

First head-to-head randomized clinical trial comparing the efficacy and safety of Toujeo (insulin glargine 300 Units/mL) versus insulin degludec.

Yokogawa Electric Corporation (TOKYO: 6841) announces the December 4 release of FAST/TOOLS R10.03, the latest version of a web-based real-time operations management and visualization software solution.

CRESEMBA is a novel antifungal medicine for the treatment of adult patients with diagnosed invasive aspergillosis and mucormycosis1, two serious infections associated with significant morbidity and mortality among immunocompromised patients, such as those with advanced HIV and those with cancer.

Takeda Pharmaceutical Company Limited [TSE: 4502] announced today that Toshio Fujimoto, MD, MBA has been appointed General Manager of Takeda’s Health Innovation Park in Shonan

Yale researchers have successfully used a nanotechnology-enhanced drug therapy to suppress inflammation and prevent infection in new kidney transplants.